Related Experiment Video

Updated: Sep 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials

Karen E Friday1

  • 1Department Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA. fridayk@tulane.edu

Experimental Biology and Medicine (Maywood, N.J.)
|July 24, 2003
PubMed

Insights

Effective management of elevated cholesterol, particularly LDL-C, is crucial for reducing coronary heart disease (CHD) risk. Aggressive statin therapy and attention to HDL-C and triglycerides can improve patient outcomes and cardiovascular event reduction.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pharmacology

Background:

  • Elevated low-density lipoprotein cholesterol (LDL-C) is a significant risk factor for coronary heart disease (CHD).
  • Statins are effective in lowering LDL-C and reducing CHD events, but many patients do not achieve target levels.
  • National Cholesterol Education Program (NCEP) guidelines highlight the importance of LDL-C, HDL-C, and triglycerides in cardiovascular risk assessment.

Purpose of the Study:

  • To review the evidence supporting more aggressive LDL-C lowering for greater clinical benefit.
  • To emphasize the role of high-density lipoprotein cholesterol (HDL-C) and triglyceride management in dyslipidemia.
  • To advocate for improved clinical titration of lipid-lowering medications to achieve treatment goals.

Main Methods:

  • Review of epidemiologic evidence and large-scale intervention trials on lipid management.
  • Analysis of current National Cholesterol Education Program (NCEP) guidelines (ATP II and ATP III).
  • Synthesis of recent studies on statin efficacy and cardioprotective effects.

Main Results:

  • Aggressive LDL-C lowering may offer greater clinical benefits, even in moderately hypercholesterolemic individuals.
  • Statins demonstrate cardioprotective effects in high-risk individuals, including those with baseline LDL-C <100 mg/dl.
  • NCEP guidelines increasingly emphasize HDL-C and triglyceride levels as major CHD risk factors.

Conclusions:

  • Optimizing lipid and lipoprotein profiles through effective medication management is essential for reducing cardiovascular events.
  • Clinicians must improve medication titration to help patients achieve NCEP-defined lipid goals.
  • Comprehensive management of dyslipidemia, including LDL-C, HDL-C, and triglycerides, is key to preventing CHD.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...